Histone signature of metanephric mesenchyme cell lines

Epigenetics

Volumn 8, Issue 9, 2013, Pages 970-978

  McLaughlin, Nathan ^a   Yao, Xiao ^a   Li, Yuwen ^a   Saifudeen, Zubaida ^a   El Dahr, Samir S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ChIP Seq; Histone methylation; Histone modifications; Kidney development; Metanephric mesenchyme cells; Nephron progenitors

Indexed keywords

BETA CATENIN; COLLAGEN TYPE 1; HISTONE; HISTONE H327ME3; HISTONE H3K9ME2; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX8; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; WNT3A PROTEIN; WNT4 PROTEIN;

ANIMAL CELL; ARTICLE; CHROMATIN; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; GENOME; MESENCHYME CELL; METANEPHRIC MESENCHYME CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WNT SIGNALING PATHWAY;

CHIP-SEQ; HISTONE METHYLATION; HISTONE MODIFICATIONS; KIDNEY DEVELOPMENT; METANEPHRIC MESENCHYME CELLS; NEPHRON PROGENITORS;

ANIMALS; BETA CATENIN; CELL LINE; CHROMATIN; EPIGENESIS, GENETIC; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONES; KIDNEY; MESENCHYMAL STROMAL CELLS; MESODERM; METHYLATION; MICE; NEPHRONS; POLYCOMB REPRESSIVE COMPLEX 2; PROMOTER REGIONS, GENETIC; WNT SIGNALING PATHWAY;

EID: 84883543522     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.25753     Document Type: Article

References (34)

1. van Steensel B, Delrow J, Henikoff S. Chromatin profiling using targeted DNA adenine methyltransferase. Nat Genet 2001; 27:304-8; PMID:11242113; http:// dx.doi.org/10.1038/85871
2. Handel AE, Ebers GC, Ramagopalan SV. Epigenetics: molecular mechanisms and implications for disease. Trends Mol Med 2010; 16:7-16; PMID:20022812; http://dx.doi.org/10.1016/j.molmed.2009.11.003
3. Bonasio R, Tu S, Reinberg D. Molecular signals of epigenetic states. Science 2010; 330:612-6; PMID:21030644; http://dx.doi.org/10.1126/science. 1191078
4. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315-26; PMID:16630819; http://dx.doi. org/10.1016/j.cell.2006.02.041
5. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 2009; 4:80-93; PMID:19128795; http://dx.doi. org/10.1016/j.stem.2008.11.011
6. Aldiri I, Vetter ML. PRC2 during vertebrate organogenesis: a complex in transition. Dev Biol 2012; 367:91-9; PMID:22565092; http://dx.doi.org/10.1016/j. ydbio.2012.04.030
7. Costantini F, Kopan R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev Cell 2010; 18:698-712; PMID:20493806; http://dx.doi.org/10.1016/j.devcel. 2010.04.008
8. Dressler GR. Advances in early kidney specification, development and patterning. Development 2009; 136:3863-74; PMID:19906853; http://dx.doi. org/10.1242/dev.034876
9. Little M, Georgas K, Pennisi D, Wilkinson L. Kidney development: two tales of tubulogenesis. Curr Top Dev Biol 2010; 90:193-229; PMID:20691850; http:// dx.doi.org/10.1016/S0070-2153(10)90005-7
10. Kobayashi A, Valerius MT, Mugford JW, Carroll TJ, Self M, Oliver G, et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008; 3:169-81; PMID:18682239; http:// dx.doi.org/10.1016/j.stem.2008.05.020
11. Self M, Lagutin OV, Bowling B, Hendrix J, Cai Y, Dressler GR, et al. Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J 2006; 25:5214-28; PMID:17036046; http://dx.doi.org/10.1038/sj.emboj.7601381
12. Brown AC, Muthukrishnan SD, Guay JA, Adams DC, Schafer DA, Fetting JL, et al. Role for compartmentalization in nephron progenitor differentiation. Proc Natl Acad Sci U S A 2013; 110:4640-5; PMID:23487745; http://dx.doi.org/10.1073/pnas.1213971110
13. Karner CM, Das A, Ma Z, Self M, Chen C, Lum L, et al. Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development. Development 2011; 138:1247-57; PMID:21350016; http://dx.doi.org/10.1242/ dev.057646
14. Park JS, Ma W, O'Brien LL, Chung E, Guo JJ, Cheng JG, et al. Six2 and Wnt regulate self-renewal and commitment of nephron progenitors through shared gene regulatory networks. Dev Cell 2012; 23:637-51; PMID:22902740; http://dx.doi.org/10.1016/j.devcel. 2012.07.008
15. Carroll TJ, Park JS, Hayashi S, Majumdar A, McMahon AP. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 2005; 9:283-92; PMID:16054034; http://dx.doi. org/10.1016/j.devcel.2005.05.016
16. Tanigawa S, Wang H, Yang Y, Sharma N, Tarasova N, Ajima R, et al. Wnt4 induces nephronic tubules in metanephric mesenchyme by a non-canonical mechanism. Dev Biol 2011; 352:58-69; PMID:21256838; http://dx.doi.org/10.1016/j.ydbio.2011.01.012
17. Valerius MT, Patterson LT, Witte DP, Potter SS. Microarray analysis of novel cell lines representing two stages of metanephric mesenchyme differentiation. Mech Dev 2002; 110:151-64; PMID:11744376; http://dx.doi.org/10.1016/S0925-4773(01)00581-0
18. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010; 28:495-501; PMID:20436461; http://dx.doi. org/10.1038/nbt.1630
19. Nicol JW, Helt GA, Blanchard SG Jr., Raja A, Loraine AE. The Integrated Genome Browser: free software for distribution and exploration of genome-scale datasets. Bioinformatics 2009; 25:2730-1; PMID:19654113; http://dx.doi.org/10.1093/bioinformatics/btp472
20. Sanna-Cherchi S, Kiryluk K, Burgess KE, Bodria M, Sampson MG, Hadley D, et al. Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Genet 2012; 91:987-97; PMID:23159250; http://dx.doi.org/10.1016/j. ajhg.2012.10.007
21. Köttgen A, Pattaro C, Böger CA, Fuchsberger C, Olden M, Glazer NL, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet 2010; 42:376-84; PMID:20383146; http://dx.doi. org/10.1038/ng.568
22. Akhtar-Zaidi B, Cowper-Sal-lari R, Corradin O, Saiakhova A, Bartels CF, Balasubramanian D, et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science 2012; 336:736-9; PMID:22499810; http://dx.doi.org/10.1126/science. 1217277
23. Xu CR, Cole PA, Meyers DJ, Kormish J, Dent S, Zaret KS. Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. Science 2011; 332:963-6; PMID:21596989; http://dx.doi. org/10.1126/science.1202845
24. Azuara V, Perry P, Sauer S, Spivakov M, Jørgensen HF, John RM, et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 2006; 8:532-8; PMID:16570078; http://dx.doi.org/10.1038/ncb1403
25. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2010; PMID:21160473
26. Eeckhoute J, Lupien M, Meyer CA, Verzi MP, Shivdasani RA, Liu XS, et al. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res 2009; 19:372-80; PMID:19129543; http://dx.doi.org/10.1101/ gr.084582.108
27. Metsuyanim S, Pode-Shakked N, Schmidt-Ott KM, Keshet G, Rechavi G, Blumental D, et al. Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes. Stem Cells 2008; 26:1808-17; PMID:18467665; http:// dx.doi.org/10.1634/stemcells.2007-0322
28. Wyngaarden LA, Delgado-Olguin P, Su IH, Bruneau BG, Hopyan S. Ezh2 regulates anteroposterior axis specification and proximodistal axis elongation in the developing limb. Development 2011; 138:3759-67; PMID:21795281; http://dx.doi.org/10.1242/ dev.063180
29. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20:1123-36; PMID:16618801; http://dx.doi. org/10.1101/gad.381706
30. Mackenzie HS, Lawler EV, Brenner BM. Congenital oligonephropathy: The fetal flaw in essential hypertension? Kidney Int Suppl 1996; 55:S30-4; PMID:8743507
31. Saifudeen Z, Diavolitsis V, Stefkova J, Dipp S, Fan H, El-Dahr SS. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression. J Biol Chem 2005; 280:23094-102; PMID:15805112; http://dx.doi. org/10.1074/jbc.M414575200
32. Saifudeen Z, Dipp S, Fan H, El-Dahr SS. Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation. Am J Physiol Renal Physiol 2005; 288:F899-909; PMID:15632413; http://dx.doi. org/10.1152/ajprenal.00370.2004
33. Van Bodegom D, Saifudeen Z, Dipp S, Puri S, Magenheimer BS, Calvet JP, et al. The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression. J Biol Chem 2006; 281:31234-44; PMID:16931520; http://dx.doi.org/10.1074/jbc. M606510200
34. Karner CM, Das A, Ma Z, Self M, Chen C, Lum L, et al. Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development. Development 2011; 138:1247-57; PMID:21350016; http://dx.doi.org/10.1242/ dev.057646